↓ Skip to main content

Temporal Control of Gene Deletion in Sensory Ganglia Using a Tamoxifen-Inducible Advillin-CreERT2 Recombinase Mouse

Overview of attention for article published in Molecular Pain, January 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
1 X user
patent
6 patents

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
141 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Temporal Control of Gene Deletion in Sensory Ganglia Using a Tamoxifen-Inducible Advillin-CreERT2 Recombinase Mouse
Published in
Molecular Pain, January 2011
DOI 10.1186/1744-8069-7-100
Pubmed ID
Authors

Joanne Lau, Michael S Minett, Jing Zhao, Ulla Dennehy, Fan Wang, John N Wood, Yury D Bogdanov

Abstract

Tissue-specific gene deletion has proved informative in the analysis of pain pathways. Advillin has been shown to be a pan-neuronal marker of spinal and cranial sensory ganglia. We generated BAC transgenic mice using the Advillin promoter to drive a tamoxifen-inducible CreERT2 recombinase construct in order to be able to delete genes in adult animals. We used a floxed stop ROSA26LacZ reporter mouse to examine functional Cre expression, and analysed the behaviour of mice expressing Cre recombinase.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
France 2 1%
Sweden 1 <1%
Denmark 1 <1%
United Kingdom 1 <1%
Unknown 133 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 40 28%
Researcher 28 20%
Student > Doctoral Student 9 6%
Student > Bachelor 9 6%
Student > Master 8 6%
Other 21 15%
Unknown 26 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 50 35%
Neuroscience 35 25%
Biochemistry, Genetics and Molecular Biology 11 8%
Medicine and Dentistry 7 5%
Unspecified 1 <1%
Other 6 4%
Unknown 31 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2023.
All research outputs
#3,415,350
of 25,374,647 outputs
Outputs from Molecular Pain
#53
of 669 outputs
Outputs of similar age
#19,663
of 190,475 outputs
Outputs of similar age from Molecular Pain
#3
of 36 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 669 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,475 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.